Examination Report |
1 | TM-1 | 10 Apr 2012 |
2 | Reply to Exam Report (MIS-R) | 26 Nov 2013 |
3 | Opponents Affidavit Rule | 09 Jan 2017 |
4 | Evidence Affidavit Under Rule 47 (TOP) | 07 Apr 2017 |
5 | Correspondence | 22 May 2017 |
6 | Affidavit | 27 Jun 2017 |
7 | Journal Copy | 19 Jun 2018 |
8 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 14 Nov 2022 |
1 | Hearing Notice (Adjourned) | 2189560 | 1207290 | 06 Jul 2015 |
2 | Tribunal Accepted Notice for : 2312476 | 2269725 | 1226445 | 11 Aug 2015 |
3 | Opposition Counter Statement | 4130356 | 20 Oct 2016 | |
4 | Hearing Notice | 14323353 | 5760552 | 11 Nov 2022 |
5 | Hearing Notice | 14944571 | 5887487 | 13 Mar 2023 |
The application for Fametrim was made on 10 April 2012.
The trademark applicant for Fametrim is BLISS GVS PHARMA.
Fametrim is applied in class(es) 5.
Application for Fametrim is on Opposed stage.
Application Id allotted to Fametrim is 2312476.
Trademark agent or attorney for the application is Innovative Consultants.
Fametrim filed with the Intellectual property office as a DEVICE.